Bionic scaffolds with integrated structural components based on low‐temperature deposition manufacturing 3D printing technology for the treatment of meniscus defects
{"title":"Bionic scaffolds with integrated structural components based on low‐temperature deposition manufacturing 3D printing technology for the treatment of meniscus defects","authors":"Shi Shen, Yujie Li, Mingxue Chen, Weimin Guo, Shuang Gao, Zengzeng Zhang, Naiqiang Zhuo, Shuyun Liu, Quanyi Guo","doi":"10.1002/btm2.70022","DOIUrl":null,"url":null,"abstract":"Tissue engineering provides a promising avenue for treating meniscus defects. In this study, a novel polycaprolactone (PCL)/collagen type I (COL I) meniscus scaffold was fabricated using low temperature deposition manufacturing (LDM) 3D printing technology. The scaffold had a ring and radial fiber structure, and its composition and structure were double bionic of the natural meniscus. In vitro experiments showed that the scaffold had good biological properties, which could promote the proliferation of meniscus fibrochondrocytes (MFCs) and increase the secretion of collagen and glycosaminoglycan. Moreover, the scaffold had excellent mechanical properties and could withstand various stress loads from the femur and tibia. The integrity of the scaffold structure was maintained to provide sufficient time and space for tissue regeneration. The PCL/ COL I scaffold has shown good therapeutic effect in a rabbit meniscus defect model and promotes meniscus regeneration. The results of experiments in rabbits suggest that the scaffold may recruit stem cells and differentiate into fibrochondrocytes in the knee joint, which needs to be verified by further experiments. This study introduces a method of fabricating a new structural composition double bionic meniscus scaffold by LDM technology and verifies its ability to promote cell proliferation, increase the secretion of the extracellular matrix of fibrocartilage, and regulate the microenvironment of cell growth. In addition, this scaffold has achieved good results in repairing meniscus defects in small animal models. Our findings strongly indicate that the PCL/COL I biomimetic meniscus scaffold prepared using 3D‐LDM technology holds great promise for repairing and regenerating damaged menisci.","PeriodicalId":9263,"journal":{"name":"Bioengineering & Translational Medicine","volume":"8 1","pages":""},"PeriodicalIF":6.1000,"publicationDate":"2025-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioengineering & Translational Medicine","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1002/btm2.70022","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Tissue engineering provides a promising avenue for treating meniscus defects. In this study, a novel polycaprolactone (PCL)/collagen type I (COL I) meniscus scaffold was fabricated using low temperature deposition manufacturing (LDM) 3D printing technology. The scaffold had a ring and radial fiber structure, and its composition and structure were double bionic of the natural meniscus. In vitro experiments showed that the scaffold had good biological properties, which could promote the proliferation of meniscus fibrochondrocytes (MFCs) and increase the secretion of collagen and glycosaminoglycan. Moreover, the scaffold had excellent mechanical properties and could withstand various stress loads from the femur and tibia. The integrity of the scaffold structure was maintained to provide sufficient time and space for tissue regeneration. The PCL/ COL I scaffold has shown good therapeutic effect in a rabbit meniscus defect model and promotes meniscus regeneration. The results of experiments in rabbits suggest that the scaffold may recruit stem cells and differentiate into fibrochondrocytes in the knee joint, which needs to be verified by further experiments. This study introduces a method of fabricating a new structural composition double bionic meniscus scaffold by LDM technology and verifies its ability to promote cell proliferation, increase the secretion of the extracellular matrix of fibrocartilage, and regulate the microenvironment of cell growth. In addition, this scaffold has achieved good results in repairing meniscus defects in small animal models. Our findings strongly indicate that the PCL/COL I biomimetic meniscus scaffold prepared using 3D‐LDM technology holds great promise for repairing and regenerating damaged menisci.
组织工程学为治疗半月板缺损提供了一条前景广阔的途径。本研究利用低温沉积制造(LDM)三维打印技术制作了一种新型聚己内酯(PCL)/I型胶原(COL I)半月板支架。该支架具有环状和径向纤维结构,其成分和结构与天然半月板具有双重仿生性。体外实验表明,该支架具有良好的生物学特性,能促进半月板纤维软骨细胞(MFCs)的增殖,增加胶原蛋白和糖胺聚糖的分泌。此外,该支架还具有良好的机械性能,能承受来自股骨和胫骨的各种应力载荷。支架结构的完整性得以保持,为组织再生提供了充足的时间和空间。PCL/ COL I 支架在兔子半月板缺损模型中显示出良好的治疗效果,并能促进半月板再生。兔子的实验结果表明,该支架可在膝关节中招募干细胞并分化成纤维软骨细胞,这还需要进一步的实验验证。本研究介绍了一种利用 LDM 技术制造新型结构成分双仿生半月板支架的方法,并验证了其促进细胞增殖、增加纤维软骨细胞外基质分泌和调节细胞生长微环境的能力。此外,这种支架在修复小动物模型的半月板缺损方面也取得了良好的效果。我们的研究结果有力地表明,利用 3D-LDM 技术制备的 PCL/COL I 仿生物半月板支架在修复和再生受损半月板方面前景广阔。
期刊介绍:
Bioengineering & Translational Medicine, an official, peer-reviewed online open-access journal of the American Institute of Chemical Engineers (AIChE) and the Society for Biological Engineering (SBE), focuses on how chemical and biological engineering approaches drive innovative technologies and solutions that impact clinical practice and commercial healthcare products.